Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s): CLAZF

Healthcare

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID viruses on contact. R-107 targets the Achilles heel of COVID, the spike protein on the surface of the virus. R-107 releases nitric oxide, which attaches to a specific amino acid on the spike protein, thereby disabling the spike protein. The CLA-1816 provides effective pain reduction, without the risks of addiction or respiratory suppression that exist with opioid analgesics. CLA-1816 strongly binds with and activates the alpha3 glycine pain receptor in the spine. The Company has leased a laboratory, office, and archival space in Beverly, Massachusetts.

TSXV:CLAS.H - Post by User

Claritas Pharmaceuticals Inc > I see now where CLAS spends its marketing money!

<< Previous

Bullboard Posts

Next >>

Comment by PTBaileyon Nov 02, 2021 2:48pm

40 Views

Post# 34078596

RE:I see now where CLAS spends its marketing money!

TaiLakim wrote: It pays pumpers to keep pumping this stock on Stockhouse and social media!

Heck, can I sign up to be a pumper and get paid unsuspecting shareholders money?

Yours truly,
Wannabe CLAS Pumper (P.A.I.D.)

Buy shares, payday is coming. Oops, there I go pumping again.

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)